Abreos Biosciences

About:

Abreos Biosciences develops lateral flow assays that measure the activity of high value biologics.

Top Investors: MedTech Innovator, TLP Investment Partners, Triton Technology Fund

Description:

Abreos Biosciences develops lateral flow assays that measure the activity of high-value biologics. Its simple devices can be used for quality assurance, pharmacokinetic monitoring, and authentication in field, forensic, or point of care settings. We deliver value by enhancing brand protection, improving patients’ outcomes, and enabling rapid authentication for counterfeit prevention and end-user confidence. The company was founded in 2013 and headquartered in San Diego, California.

Total Funding Amount:

$8.64M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2013-01-01

Founders:

Bradley Messmer, Peter Haberz

Number of Employees:

1-10

Last Funding Date:

2020-09-15

IPO Status:

Private

Industries: